Cargando…
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma
SIMPLE SUMMARY: Cyclophilins, one of the three families of proteins with peptidyl-prolyl isomerase activity, are overexpressed in several cancers, including hepatocellular carcinoma (HCC), and this overexpression is correlated with poor prognosis. Cyclophilins play an important role in cancer progre...
Autores principales: | Simón Serrano, Sonia, Tavecchio, Michele, Mallik, Josef, Grönberg, Alvar, Elmér, Eskil, Kifagi, Chamseddine, Gallay, Philippe, Hansson, Magnus Joakim, Massoumi, Ramin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559492/ https://www.ncbi.nlm.nih.gov/pubmed/36230472 http://dx.doi.org/10.3390/cancers14194553 |
Ejemplares similares
-
Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis
por: Kuo, Joseph, et al.
Publicado: (2019) -
Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis
por: Simón Serrano, Sonia, et al.
Publicado: (2019) -
Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma
por: Simón Serrano, Sonia, et al.
Publicado: (2021) -
Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice
por: Bobardt, Michael, et al.
Publicado: (2020) -
The Cyclophilin-Binding Agent Sanglifehrin A Is a Dendritic Cell Chemokine and Migration Inhibitor
por: Immecke, Sabrina N., et al.
Publicado: (2011)